Výsledky vyhľadávania - "Uterine Cervical Neoplasms/drug therapy"

Evaluating the benefits of immunotherapy in metastatic cervical cancer: an observational retrospective analysis

Autori: Ana Isabel Martín-Quesada Lina Pérez-Mendez Natalia Dolores Pérez-Rodríguez

Zdroj: Clin Transl Oncol
Clinical & translational oncology, vol. 27, no. 8, pp. 3535-3542

Predmety: Brief Research Article, Humans, Female, Uterine Cervical Neoplasms/pathology, Uterine Cervical Neoplasms/drug therapy, Uterine Cervical Neoplasms/mortality, Uterine Cervical Neoplasms/therapy, Retrospective Studies, Middle Aged, Aged, Immunotherapy/methods, Adult, Progression-Free Survival, Antibodies, Monoclonal, Humanized/therapeutic use, Longitudinal Studies, B7-H1 Antigen/analysis, Immune Checkpoint Inhibitors/therapeutic use, Aged, 80 and over, Antineoplastic Agents, Immunological/therapeutic use, Cervical Cancer, Immunotherapy, Metastatic, Objective-Response-Rate, Progression-Free-Survival, Real-World-Evidence, Recurrent

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39921802
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F9D31B2ABC881
https://serval.unil.ch/resource/serval:BIB_F9D31B2ABC88.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_F9D31B2ABC88

Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial: Insights from the phase II PRIMMO trial

Autori: De Jaeghere, Emiel Hamerlinck, Hannelore Tuyaerts, Sandra a ďalší

Prispievatelia: De Jaeghere, Emiel Hamerlinck, Hannelore Tuyaerts, Sandra a ďalší

Zdroj: Gynecologic oncology
GYNECOLOGIC ONCOLOGY

Predmety: Antineoplastic Agents, Immunological/adverse effects, Adult, Feces/microbiology, CARCINOMA, Uterine Cervical Neoplasms, Antibodies, Monoclonal, Humanized, Feces, Antineoplastic Agents, Immunological, Endometrial cancer, Medicine and Health Sciences, Humans, Gastrointestinal Microbiome/drug effects, Uterine Cervical Neoplasms/drug therapy, IMMUNOTHERAPY, Aged, Gut microbiome, Endometrial Neoplasms/drug therapy, Gut metagenome, Middle Aged, EFFICACY, Gastrointestinal Microbiome, Endometrial Neoplasms, Antibodies, Monoclonal, Humanized/adverse effects, Cervical cancer, Immune checkpoint inhibition, Female, Human medicine, RESISTANCE

Popis súboru: application/vnd.openxmlformats-officedocument.wordprocessingml.document

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39515198
https://hdl.handle.net/10067/2104560151162165141
https://biblio.vub.ac.be/vubir/(b2b10631-2a3a-4283-b381-bd2e703f1a6d).html
http://doi.org/10.1016/j.ygyno.2024.10.020
https://biblio.ugent.be/publication/01JDYX0Y1V6VYSRBVCAZHKYAD8
https://biblio.ugent.be/publication/01JDYX0Y1V6VYSRBVCAZHKYAD8/file/01JGHWAZD2WCN1EHDKWWHDMKMM
http://hdl.handle.net/1854/LU-01JDYX0Y1V6VYSRBVCAZHKYAD8

Fertility-sparing strategy in a rare case of highly malignant Dicer-1-associated sarcoma of the cervix

Autori: J. Altmann K. Kubiak J. Sehouli a ďalší

Zdroj: Arch Gynecol Obstet

Predmety: Ribonuclease III, Cryopreservation, Adolescent, Uterine Cervical Neoplasms, Fertility Preservation, Sarcoma, Cervix Uteri, Gynecologic Oncology, DEAD-box RNA Helicases, 03 medical and health sciences, 0302 clinical medicine, Doxorubicin, Mutation, Ifosfamide/administration, Adolescent [MeSH], Ribonuclease III/genetics [MeSH], Mutation [MeSH], Sarcoma/diagnostic imaging [MeSH], Uterine Cervical Neoplasms/diagnostic imaging [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Dicer-1 sarcoma, Fertility [MeSH], Uterine Cervical Neoplasms/drug therapy [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Tomography, X-Ray Computed [MeSH], Magnetic Resonance Imaging [MeSH], Cervical sarcoma, Doxorubicin/administration, Sarcoma/drug therapy [MeSH], Fertility preservation, Fertility sparing, Humans, Female, Ifosfamide

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38976022
https://repository.publisso.de/resource/frl:6491538

Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer

Autori: Vergote, I. González-Martín, A. Fujiwara, K. a ďalší

Prispievatelia: Vergote, I. González-Martín, A. Fujiwara, K. a ďalší

Zdroj: The New England Journal of Medicine, 391, 1, pp. 44-55

Predmety: Adult, Oncologie, Uterine Cervical Neoplasms, Antibodies, Monoclonal/therapeutic use, Kaplan-Meier Estimate, Antibodies, Monoclonal/adverse effects, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal/administration & dosage, Sciences de la santé humaine, Uterine Cervical Neoplasms/mortality, Antineoplastic Combined Chemotherapy Protocols, Humans, Uterine Cervical Neoplasms/drug therapy, Human health sciences, Medical Oncology - Radboud University Medical Center, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antibodies, Monoclonal, Middle Aged, Survival Analysis, Progression-Free Survival, Neoplasm Recurrence, Local/drug therapy, Oncology, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Neoplasm Recurrence, Local, Oligopeptides

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38959480
https://hdl.handle.net/2066/310949
https://repository.ubn.ru.nl//bitstream/handle/2066/310949/310949.pdf

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study: Results from the innovaTV 205/GOG-3024/ENGOT-cx8 Study

Autori: Vergote, I. Van Nieuwenhuysen, E. O'Cearbhaill, R.E. a ďalší

Prispievatelia: Vergote, I. Van Nieuwenhuysen, E. O'Cearbhaill, R.E. a ďalší

Zdroj: J Clin Oncol
Journal of Clinical Oncology, 41, 36, pp. 5536-5549
Journal of clinical oncology, Vol. 41, no.36, p. 5536-5549 (2023)
Journal of Clinical Oncology, vol 41, iss 36
JOURNAL OF CLINICAL ONCOLOGY

Predmety: Cancer Research, Lung Neoplasms, Oncologie, Radboud University Medical Center, Uterine Cervical Neoplasms, Bevacizumab/adverse effects, Sciences de la santé humaine, Carboplatin, Anemia/drug therapy, Carboplatin/adverse effects, Local/etiology, SDG 3 - Good Health and Well-being, 3211 Oncology and carcinogenesis, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, SINGLE-ARM, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Uterine Cervical Neoplasms/drug therapy, Human health sciences, Lung Neoplasms/drug therapy, Radboudumc 17: Women's cancers Medical Oncology, Science & Technology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, 1103 Clinical Sciences, Anemia, ORIGINAL REPORTS, 3. Good health, Bevacizumab, Neoplasm Recurrence, Local, Oncology, Radboudumc 17: Women's cancers Pulmonary Diseases, Female, Neoplasm Recurrence, Local, Life Sciences & Biomedicine, PREVIOUSLY TREATED RECURRENT

Popis súboru: application/pdf; Print-Electronic

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37651655
https://dspace.library.uu.nl/handle/1874/460415
https://pure.amsterdamumc.nl/en/publications/b34872c3-ca35-4654-9b00-f19b2f583751
https://doi.org/10.1200/JCO.23.00720
https://hdl.handle.net/2066/300956
https://repository.ubn.ru.nl//bitstream/handle/2066/300956/300956.pdf
https://hdl.handle.net/2268/306150
https://doi.org/10.1200/JCO.23.00720
https://hdl.handle.net/2078.1/290106
https://escholarship.org/uc/item/5t98q2d3
https://escholarship.org/content/qt5t98q2d3/qt5t98q2d3.pdf
http://hdl.handle.net/1854/LU-01HSJVSJ4CQNVBQRYXEJSF9K4W
https://biblio.ugent.be/publication/01HSJVSJ4CQNVBQRYXEJSF9K4W/file/01HSJVSYQ590SHX73KSQWQGWP0
https://biblio.ugent.be/publication/01HSJVSJ4CQNVBQRYXEJSF9K4W
http://doi.org/10.1200/jco.23.00720

Progression-free survival as a potential surrogate end point for overall survival in advanced cervical carcinoma.

Autori: Yarza, R. Kountouri, M. Guedes, H. a ďalší

Zdroj: International journal of gynecological cancer, vol. 35, no. 2, pp. 100012

Predmety: Humans, Uterine Cervical Neoplasms/mortality, Uterine Cervical Neoplasms/therapy, Uterine Cervical Neoplasms/pathology, Uterine Cervical Neoplasms/drug therapy, Female, Progression-Free Survival, Randomized Controlled Trials as Topic, Clinical Trials, Phase II as Topic, cervical carcinoma, chemotherapy, immunotherapy, overall survival, surrogate

Popis súboru: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/39971452; info:eu-repo/semantics/altIdentifier/eissn/1525-1438; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_5E68AAFE6D775; https://serval.unil.ch/notice/serval:BIB_5E68AAFE6D77; https://serval.unil.ch/resource/serval:BIB_5E68AAFE6D77.P001/REF.pdf

Dostupnosť: https://serval.unil.ch/notice/serval:BIB_5E68AAFE6D77
https://doi.org/10.1016/j.ijgc.2024.100012
https://serval.unil.ch/resource/serval:BIB_5E68AAFE6D77.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_5E68AAFE6D775

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer

Autori: Vergote, I Van Nieuwenhuysen, E Casado, A a ďalší

Prispievatelia: Vergote, I Van Nieuwenhuysen, E Casado, A a ďalší

Zdroj: Gynecologic Oncology. 174:80-88

Predmety: Obstétrique, Vascular Endothelial Growth Factor A, Lung Neoplasms, Paclitaxel, Nintedanib, Oncologie, Uterine Cervical Neoplasms, Sciences de la santé humaine, Carboplatin, Gynécologie, Double-Blind Method, Antineoplastic Combined Chemotherapy Protocols, nintedanib, Chemotherapy, Humans, Uterine Cervical Neoplasms/drug therapy, Human health sciences, Lung Neoplasms/drug therapy, Neoplasm Recurrence, Local/pathology, Uterine Cervical Neoplasms/etiology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Obstetrics and Gynecology, 3. Good health, Cancérologie, Angiogenesis, Cervical cancer, Recurrent, Oncology, Female, Neoplasm Recurrence, Local

Popis súboru: application/pdf; No full-text files

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37167896

Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study: An Analysis From the EMBRACE-I Study

Autori: Smet, Stéphanie Spampinato, Sofia Pötter, Richard a ďalší

Prispievatelia: Smet, Stéphanie Spampinato, Sofia Pötter, Richard a ďalší

Zdroj: EMBRACE Collaborative Group 2022, 'Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer : An Analysis From the EMBRACE-I Study', International Journal of Radiation Oncology Biology Physics, vol. 112, no. 5, pp. 1177-1189. https://doi.org/10.1016/j.ijrobp.2021.11.022

Predmety: VAGINAL STENOSIS, Uterine Cervical Neoplasms, Chemoradiotherapy/adverse effects, MORBIDITY, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, QUALITY-OF-LIFE, Risk Factors, Journal Article, Humans, Uterine Cervical Neoplasms/drug therapy, Prospective Studies, Fatigue, SURVIVORS, Research Support, Non-U.S. Gov't, WORKING GROUP, Chemoradiotherapy, GUIDED ADAPTIVE BRACHYTHERAPY, DOSE-EFFECT RELATIONSHIP, PREVALENCE, 3. Good health, Multicenter Study, VOLUME, RADIATION, Female, Fatigue/etiology

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34838868
https://pure.eur.nl/en/publications/2ea24b86-4161-4544-9003-50bf617587dc
https://doi.org/10.1016/j.ijrobp.2021.11.022
https://cris.maastrichtuniversity.nl/en/publications/99d29be0-8d99-4de8-870b-92108dbe016c
https://doi.org/10.1016/j.ijrobp.2021.11.022
https://www.ncbi.nlm.nih.gov/pubmed/34838868
https://www.sciencedirect.com/science/article/pii/S036030162103220X
https://dspace.library.uu.nl/handle/1874/448149
https://pure.amsterdamumc.nl/en/publications/4d49ee24-4eb0-4a6e-baa4-5ca7f728a14c
https://doi.org/10.1016/j.ijrobp.2021.11.022

Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis

Autori: Sofia Spampinato Lars U. Fokdal Richard Pötter a ďalší

Prispievatelia: Sofia Spampinato Lars U. Fokdal Richard Pötter a ďalší

Zdroj: Spampinato, S, Fokdal, L U, Pötter, R, Haie-Meder, C, Lindegaard, J C, Schmid, M P, Sturdza, A, Jürgenliemk-Schulz, I M, Mahantshetty, U, Segedin, B, Bruheim, K, Hoskin, P, Rai, B, Huang, F, Cooper, R, van der Steen-Banasik, E, Van Limbergen, E, Sundset, M, Westerveld, H, Nout, R A, Jensen, N B K, Kirisits, C, Kirchheiner, K, Tanderup, K & EMBRACE Collaborative Group 2021, 'Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer : An EMBRACE analysis', Radiotherapy and Oncology, vol. 158, pp. 312-320. https://doi.org/10.1016/j.radonc.2021.01.019

Predmety: Urinary morbidity, Brachytherapy, Uterine Cervical Neoplasms, Brachytherapy/adverse effects, Clinical study, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Cystitis, Journal Article, IGABT, Humans, Uterine Cervical Neoplasms/drug therapy, Prospective Studies, Cystitis/epidemiology, Dose-effect relationship, Research Support, Non-U.S. Gov't, Radiotherapy Dosage, Hematology, Chemoradiotherapy, 3. Good health, Risk factors, Oncology, Radiology Nuclear Medicine and imaging, Cervical cancer, Female, Radiotherapy, Image-Guided

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/33545254
https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Ffb6cdc0d-6159-4e84-bf9d-cc4d1dfb47e4
https://europepmc.org/article/MED/33545254
https://www.sciencedirect.com/science/article/pii/S0167814021000207
https://www.ncbi.nlm.nih.gov/pubmed/33545254
https://researchinformation.amsterdamumc.org/en/publications/risk-factors-and-dose-effects-for-bladder-fistula-bleeding-and-cy
http://www.ncbi.nlm.nih.gov/pubmed/33545254
https://dspace.library.uu.nl/handle/1874/445303
https://pure.amsterdamumc.nl/en/publications/5f9fcfbc-c663-4dc7-b57c-c993bd5aa8b4
https://doi.org/10.1016/j.radonc.2021.01.019
http://www.scopus.com/inward/record.url?scp=85101119760&partnerID=8YFLogxK
https://pure.au.dk/portal/en/publications/38de25a4-2eb9-44d1-a7bc-478c53160a19
https://doi.org/10.1016/j.radonc.2021.01.019

Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study

Autori: Petric, Primoz Lindegaard, Jacob C. Sturdza, Alina a ďalší

Prispievatelia: Petric, Primoz Lindegaard, Jacob C. Sturdza, Alina a ďalší

Zdroj: Petric, P, Lindegaard, J C, Sturdza, A, Fokdal, L, Kirchheiner, K, Tan, L T, Schmid, M P, Haie-Meder, C, Jürgenliemk-Schulz, I M, van Limbergen, E, Hoskin, P, Gillham, C, Tharavichitkul, E, Mahantshetty, U, Villafranca, E, Tanderup, K, Kirisits, C & Pötter, R 2021, 'Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study', Radiotherapy and Oncology, vol. 157, pp. 24-31. https://doi.org/10.1016/j.radonc.2021.01.005

Predmety: 2720 Hematology, Brachytherapy, Uterine Cervical Neoplasms, 610 Medicine & health, Nuclear Medicine and imaging, 03 medical and health sciences, 0302 clinical medicine, Cervix cancer, Journal Article, 2741 Radiology, Nuclear Medicine and Imaging, Humans, Uterine Cervical Neoplasms/drug therapy, Neoplasm Staging, Image guided brachytherapy, Research Support, Non-U.S. Gov't, Radiotherapy Dosage, Hematology, Chemoradiotherapy, Middle Aged, 10044 Clinic for Radiation Oncology, 3. Good health, Treatment Outcome, Oncology, Radiology Nuclear Medicine and imaging, 2730 Oncology, Female, Radiology

Popis súboru: application/pdf; Petric-2021-33476724.pdf - application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/33476724
https://www.sciencedirect.com/science/article/pii/S0167814021000050
https://www.ncbi.nlm.nih.gov/pubmed/33476724
https://pubmed.ncbi.nlm.nih.gov/33476724/
https://dspace.library.uu.nl/handle/1874/445298
https://www.zora.uzh.ch/id/eprint/215984/
https://doi.org/10.5167/uzh-215984
https://pure.au.dk/portal/en/publications/1823c7ac-0a5a-4a42-8ae6-60391ba0bcc3
http://www.scopus.com/inward/record.url?scp=85100055420&partnerID=8YFLogxK
https://doi.org/10.1016/j.radonc.2021.01.005

The enzyme subunit SubA of Shiga toxin-producing E. coli strains demonstrates comparable intracellular transport and cytotoxic activity as the holotoxin SubAB in HeLa and HCT116 cells in vitro

Autori: Katharina Sessler Panagiotis Papatheodorou Fanny Wondany a ďalší

Zdroj: Arch Toxicol

Predmety: GRP78, 0301 basic medicine, Molecular chaperones, Uterine Cervical Neoplasms, Subtilase cytotoxin, 03 medical and health sciences, Intrazellulärer Transport, Molecular Toxicology, Cellular uptake, Escherichia coli, Humans, Glycosides, Subtilisins, Endoplasmic Reticulum Chaperone BiP, Heat-Shock Proteins, 0303 health sciences, Shiga-Toxigenic Escherichia coli, Shiga toxin-producing Escherichia coli (STEC), Hitzeschock-Proteine, Escherichia coli Proteins, Biological Transport, HCT116 Cells, Triterpenes, 3. Good health, STEC, Shiga-toxigenic Escherichia coli, 13. Climate action, Colonic Neoplasms, Shiga toxins, Heat-shock proteins, Female, Escherichia coli Proteins/metabolism [MeSH], Glycosides/pharmacology [MeSH], Uterine Cervical Neoplasms/pathology [MeSH], Triterpenes/pharmacology [MeSH], Colonic Neoplasms/pathology [MeSH], HCT116 Cells [MeSH], Subtilisins/metabolism [MeSH], Biological Transport [MeSH], Subtilisins/pharmacology [MeSH], Female [MeSH], Escherichia coli Proteins/pharmacology [MeSH], Heat-Shock Proteins/metabolism [MeSH], Humans [MeSH], Uterine Cervical Neoplasms/drug therapy [MeSH], Shiga toxin-producing, Intracellular transport, Colonic Neoplasms/drug therapy [MeSH], Shiga-Toxigenic Escherichia coli/metabolism [MeSH], Triterpenes/metabolism [MeSH], HeLa Cells [MeSH], Glycosides/metabolism [MeSH], HeLa Cells

Popis súboru: application/pdf

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00204-020-02965-2.pdf
https://pubmed.ncbi.nlm.nih.gov/33483759
https://link.springer.com/article/10.1007/s00204-020-02965-2
https://link.springer.com/content/pdf/10.1007/s00204-020-02965-2.pdf
https://www.scilit.net/article/73780441bfa74e6b49af9b7aaac133d9?action=show-references
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904543
https://pubmed.ncbi.nlm.nih.gov/33483759/
https://paperity.org/p/260270696/the-enzyme-subunit-suba-of-shiga-toxin-producing-e-coli-strains-demonstrates-comparable
https://repository.publisso.de/resource/frl:6451715

Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)

Autori: Christina Kuhn Eileen Deuster Aurelia Vattai a ďalší

Zdroj: J Cancer Res Clin Oncol

Predmety: ddc:610, Computational Biology, Uterine Cervical Neoplasms, Female [MeSH], Signal Transduction/genetics [MeSH], Cell Line, Tumor [MeSH], Cell Movement/genetics [MeSH], Original Article – Cancer Research, Humans [MeSH], Plasminogen activator inhibitor type 1 (PAI-1), Receptors, Prostaglandin E, EP3 Subtype/genetics [MeSH], Survival Analysis [MeSH], Uterine Cervical Neoplasms/drug therapy [MeSH], Cell Movement/drug effects [MeSH], Dinoprostone/analogs, Uterine Cervical Neoplasms/pathology [MeSH], Urokinase-type plasminogen activator receptor (uPAR), Prostaglandin E, Uterine Cervical Neoplasms/genetics [MeSH], Prognosis [MeSH], Dinoprostone/pharmacology [MeSH], Signal Transduction/drug effects [MeSH], Cervical cancer, Dinoprostone/genetics [MeSH], Receptors, Urokinase Plasminogen Activator/genetics [MeSH], HeLa Cells [MeSH], Computational Biology/methods [MeSH], Prognosis, Survival Analysis, Dinoprostone, Receptors, Urokinase Plasminogen Activator, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Cell Movement, Cell Line, Tumor, Receptors, Prostaglandin E, EP3 Subtype, Humans, Female, HeLa Cells, Signal Transduction

Popis súboru: application/pdf

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00432-020-03272-0.pdf
https://pubmed.ncbi.nlm.nih.gov/32488496
https://epub.ub.uni-muenchen.de/73161/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382663
https://link.springer.com/content/pdf/10.1007/s00432-020-03272-0.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382663
https://www.ncbi.nlm.nih.gov/pubmed/32488496
https://link.springer.com/article/10.1007/s00432-020-03272-0
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/77300
https://nbn-resolving.org/urn:nbn:de:bvb:384-opus4-773005
https://opus.bibliothek.uni-augsburg.de/opus4/files/77300/Ye2020_Article_ProstaglandinE2Receptor3EP3Sig.pdf
https://doi.org/10.1007/s00432-020-03272-0
https://repository.publisso.de/resource/frl:6469362
https://epub.ub.uni-muenchen.de/73161/

Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3

Autori: Jung-Yun Lee Yoo-Young Lee Jeong-Yeol Park a ďalší

Prispievatelia: Jung-Yun Lee Yoo-Young Lee Jeong-Yeol Park a ďalší

Zdroj: J Gynecol Oncol

Predmety: Ovarian Neoplasms, Ovarian Neoplasms* / drug therapy, Female* / drug therapy, Overall Survival, Genital Neoplasms, Female, Poly(ADP-ribose) Polymerase Inhibitors / adverse effects, Uterine Cervical Neoplasms, Antineoplastic Agents, Hyperthermic Intraperitoneal Chemotherapy, Review Article, Poly(ADP-ribose) Polymerase Inhibitors, 3. Good health, Poly(ADP-Ribose) Polymerase Inhibitor, Antineoplastic Agents* / therapeutic use, Uterine Cervical Neoplasms* / drug therapy, Ovarian Neoplasms* / pathology, Humans, Female, Immunotherapy, Molecular Targeted Therapy, Genital Neoplasms

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/36890294

Sawhorse-type diruthenium tetracarbonyl complexes containing porphyrin-derived ligands as highly selective photosensitizers for female reproductive cancer cells.

Autori: Schmitt, F. Auzias, M. Stepnicka, P. a ďalší

Predmety: Antineoplastic Agents/chemical synthesis, Antineoplastic Agents/chemistry, Carcinoma/drug therapy, Cell Line, Tumor, Cell Survival/drug effects, Cells, Cultured, Electrochemistry, Female, Fibroblasts/cytology, Fibroblasts/drug effects, Humans, Molecular Structure, Organometallic Compounds/chemical synthesis, Organometallic Compounds/chemistry, Ovarian Neoplasms/drug therapy, Photosensitizing Agents/chemical synthesis, Photosensitizing Agents/chemistry, Porphyrins/chemical synthesis, Porphyrins/chemistry, Spectrum Analysis, Uterine Cervical Neoplasms/drug therapy

Popis súboru: application/pdf

Relation: Journal of Biological Inorganic Chemistry; 1432-1327[electronic]; https://iris.unil.ch/handle/iris/95141; serval:BIB_238114A205C4; 000266924400006

Dostupnosť: https://iris.unil.ch/handle/iris/95141
https://doi.org/10.1007/s00775-009-0482-z

Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV + Cancers.

Autori: Galliverti, G. Wullschleger, S. Tichet, M. a ďalší

Predmety: Animals, Antineoplastic Agents, Immunological/pharmacology, CD8-Positive T-Lymphocytes/immunology, CTLA-4 Antigen/antagonists & inhibitors, Disease Models, Animal, Drug Synergism, Female, Humans, Immunosuppression, Immunotherapy/methods, Mice, Myeloid Cells/drug effects, Myeloid Cells/immunology, Nanoparticles/administration & dosage, Papillomaviridae/immunology, Papillomavirus E7 Proteins/immunology, Papillomavirus E7 Proteins/metabolism, Papillomavirus Infections/drug therapy, Papillomavirus Infections/immunology, Papillomavirus Infections/virology, Papillomavirus Vaccines/administration & dosage, Papillomavirus Vaccines/immunology, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Tumor Microenvironment, Uterine Cervical Neoplasms/drug therapy, Uterine Cervical Neoplasms/immunology, Uterine Cervical Neoplasms/pathology, Uterine Cervical Neoplasms/virology

Relation: Cancer Immunology Research; https://iris.unil.ch/handle/iris/92964; serval:BIB_04D464D7C6BB; 000505667700013

Dostupnosť: https://iris.unil.ch/handle/iris/92964
https://doi.org/10.1158/2326-6066.CIR-19-0315

Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice.

Autori: Decrausaz, L. Revaz, V. Bobst, M. a ďalší

Predmety: Alphapapillomavirus/immunology, Animals, CD8-Positive T-Lymphocytes/immunology, Female, Genitalia, Female/immunology, Interferon-gamma/immunology, Mice, Inbred C57BL, Mucous Membrane/immunology, Papillomavirus E7 Proteins/immunology, Papillomavirus Infections/complications, Papillomavirus Infections/drug therapy, Papillomavirus Vaccines/administration & dosage, Tumor Virus Infections/complications, Tumor Virus Infections/drug therapy, Uterine Cervical Neoplasms/drug therapy, Uterine Cervical Neoplasms/immunology

Relation: International Journal of Cancer; https://iris.unil.ch/handle/iris/217234; serval:BIB_C8FA50D44220; 000276928700020

Dostupnosť: https://iris.unil.ch/handle/iris/217234
https://doi.org/10.1002/ijc.24949

Salvage chemotherapy with mitomycin, vindesine, and cisplatin (MiViP) in recurrent carcinoma of the cervix.

Autori: Delaloye, J.F. Leyvraz, S. Outcha Adjahoto, E. a ďalší

Predmety: Adult, Aged, Antibiotics, Antineoplastic/administration & dosage, Antineoplastic/adverse effects, Antineoplastic Agents/administration & dosage, Antineoplastic Agents/adverse effects, Antineoplastic Agents, Phytogenic/administration & dosage, Phytogenic/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Bone Marrow/drug effects, Carcinoma/drug therapy, Cisplatin/administration & dosage, Cisplatin/adverse effects, Disease Progression, Female, Humans, Middle Aged, Mitomycins/administration & dosage, Mitomycins/adverse effects, Neoplasm Recurrence, Local/drug therapy, Remission Induction, Salvage Therapy, Survival Rate, Uterine Cervical Neoplasms/drug therapy, Vindesine/administration & dosage, Vindesine/adverse effects

Relation: American journal of clinical oncology; https://iris.unil.ch/handle/iris/215599; serval:BIB_9EFF64AFF43B; A1996UC42300024; 8610651

Dostupnosť: https://iris.unil.ch/handle/iris/215599
https://doi.org/10.1097/00000421-199604000-00024

A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer

Prispievatelia: Kyung Hwan Kim Jee Suk Chang Hwa Kyung Byun a ďalší

Predmety: Chemoradiotherapy, Female, Humans, Treatment Outcome, Uterine Cervical Neoplasms* / drug therapy, Uterine Cervical Neoplasms* / therapy, Cancer-associated Fibroblasts, Cervical Cancer, Gene Signature

Relation: JOURNAL OF GYNECOLOGIC ONCOLOGY; J01428; https://ir.ymlib.yonsei.ac.kr/handle/22282913/187909; T202200252

Dostupnosť: https://ir.ymlib.yonsei.ac.kr/handle/22282913/187909
https://doi.org/10.3802/jgo.2022.33.e7

Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.

Autori: Vergote, Ignace González-Martín, Antonio Fujiwara, Keiichi a ďalší

Zdroj: New England Journal of Medicine, 391 (1), 44 - 55 (2024-07-04)

Predmety: Antibodies, Monoclonal, Humans, Female, Middle Aged, Adult, Aged, Kaplan-Meier Estimate, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Antibodies, Monoclonal/administration & dosage, Survival Analysis, Progression-Free Survival, Aged, 80 and over, Uterine Cervical Neoplasms/drug therapy, Uterine Cervical Neoplasms/mortality, Neoplasm Recurrence, Local/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie

Relation: http://www.nejm.org/doi/pdf/10.1056/NEJMoa2313811; urn:issn:0028-4793; urn:issn:1533-4406

Prístupová URL adresa: https://orbi.uliege.be/handle/2268/320411

HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells

Autori: T-C Wu Joon-Yong Chung Kyung Hee Noh a ďalší

Prispievatelia: T-C Wu Joon-Yong Chung Kyung Hee Noh a ďalší

Zdroj: Cancer Research. 77:5039-5053

Predmety: Neoplastic Stem Cells/drug effects, 0301 basic medicine, Breast Neoplasms/immunology, Neoplastic Stem Cells/immunology, Drug Resistance, Histones/metabolism, Apoptosis, Histone Deacetylase 1, Mice, SCID, Epigenesis, Genetic, Histones, Mice, Neoplasm/drug effects, Mice, Inbred NOD, Uterine Cervical Neoplasms/pathology, Uterine Cervical Neoplasms/drug therapy, Tumor, Cultured, Uterine Cervical Neoplasms/immunology, Breast Neoplasms/pathology, Neoplasm/immunology, Neoplastic Stem Cells/pathology, Acetylation, Nanog Homeobox Protein, Prognosis, Combined Modality Therapy, Drug Resistance, Multiple, Tumor Cells, 3. Good health, Uterine Cervical Neoplasms/metabolism, Neoplastic Stem Cells, Female, Transcriptional Activation, Nanog Homeobox Protein/genetics, Nanog Homeobox Protein/metabolism, Breast Neoplasms, SCID, Histone Deacetylase 1/metabolism, 03 medical and health sciences, Breast Neoplasms/drug therapy, Neoplastic Stem Cells/metabolism, Biomarkers, Tumor, Animals, Humans, Cell Proliferation, Neoplasm Staging, Multiple/immunology, Xenograft Model Antitumor Assays, Genetic, Histone Deacetylase 1/genetics, Breast Neoplasms/metabolism, Drug Resistance, Neoplasm, Inbred NOD, Multiple/drug effects, Biomarkers, Epigenesis

Prístupová URL adresa: https://cancerres.aacrjournals.org/content/canres/77/18/5039.full.pdf
https://pubmed.ncbi.nlm.nih.gov/28716899
https://oak.kribb.re.kr/handle/201005/17495
https://pubmed.ncbi.nlm.nih.gov/28716899/
https://yonsei.pure.elsevier.com/en/publications/hdac1-upregulation-by-nanog-promotes-multidrug-resistance-and-a-s
https://europepmc.org/article/PMC/PMC8171587
https://cancerres.aacrjournals.org/content/77/18/5039
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171587